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Abstract: Eryngium L. is the largest and arguably the most taxonomically complex genus of the family Apiaceae. The 
genus has approximately 250 species throughout the world, with the center of diversity in South America. Some Eryngium 
species are cultivated as ornamental, vegetable, or medicinal crops for folk uses. With increasing chemical and biological 
investigations, Eryngium has shown its potential as pharmaceutical crops. This review focuses on phytochemistry and 
pharmacological activities of 127 compounds isolated and identified from 23 species of Eryngium, particularly non-
essential oil compounds such as terpenoids, triterpenoid saponins, flavonoids, coumarins, polyacetylenes, and steroids. 
Eryngium extracts or isolates have shown in vitro bioactivitities such as cytotoxicity against various human tumor cell 
lines, anti-inflammatory, anti-snake and scorpion venoms, antibacterial, antifungal, and antimalarial, antioxidant, and an-
tihyperglycemic effects. In vivo studies through various animal models have also shown promising results. However, 
chemical constituents and their bioactivities of most species of this highly diversified genus have not been investigated. 
The molecular mechanism of bioactivities (particularly cytotoxicity and anti-snake and scorpion venoms) of Eryngium 
isolates remains elusive. Also, anti-tumor activity of polyhydroxylated triterpenoid saponins isolated from Eryngium 
needed to be furthur explored.  
Keywords: Eryngium L., ethnobotany, phytochemistry, triterpenoid saponins, flavonoids, polyacetylenes, cytotoxicity, anti-
inflammatory activity, anti-snake and scorpion venoms effects. 
INTRODUCTION 
Eryngium L. consists of approximately 250 species in 
Eurasia, North Africa, North and South America, and Aus-
tralia [1, 2]. It is the largest and arguably the most taxonomi-
cally complex genus of the family Apiaceae [3]. Some 
species are rare or endangered, e.g., E. alpinum L., E. aristu-
latum Jeps. var. parishii (J.M. Coult. & Rose) Mathias & 
Constance, E. constancei Sheikh, E. cuneifolium Small, E. 
viviparum [4-7]. Wolff’s (1913) treatment of Eryngium is the 
most comprehensive and predominant: two groups were 
recognized within the genus Eryngium: “Species 
gerontogeae” representing 12 sections from the Old World 
(Africa, Europe, and Asia) and “Species americanae and 
australienses” including 22 sections from the New World 
(Americas and Australia) [8]. Based on morphology, Wörz 
(2005) proposed five subgenera within Eryngium: subg. 
Eryngium, subg. Fruticosa, subg. Monocotyloidea, subg. 
Semiaquatica, and subg. Foetida with the subg. Eryngium 
occurring in Europe, Western Asia and North Africa, the 
other four subgenera mostly in the New World and in 
Australia [2, 9]. However, Wörz’s classification is not 
supported by phylogenic data. Recent infrageneric 
relationship analysis of Calviño et al. (2007) using sequence 
data from the chloroplast DNA trnQ-trnK 5’-exon and  
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nuclear ribosomal DNA ITS regions of 118 species support 
Wolff’s two-group classification [3]. Calviño et al. (2007) 
recognized two subgenera within the genus: subg. Eryngium 
and subg. Monocotyloidea [3].  
Like many other members of the celery or carrot family, 
Eryngium has been used as ornamental, vegetable, or me-
dicinal plants. Some species, such as E. foetidum L., E. mari-
timum L., E. planum L., E. dichotomum Desf., E. campestre 
L. and E. creticum Lam. have been used as food or in tradi-
tional medicine locally or worldwide [10]. E. foetidum and 
E. caucasicum Trautv. are cultivated as leaf vegetable crops 
in Asia and Africa [11, 12]. The fruits of E. foetidum were 
taken as food in Nigeria. The plant is indigenous to Tropical 
America and the West Indies where it is used as medicine 
and food some having domesticated the plant in their kitchen 
gardens and orchards. It has become naturalized and often is 
cultivated across South Asia, the Pacific islands, Tropical 
Africa and the warmer southern parts of Europe [13].  
Some species have been used in folk medicine. E. cam-
pestre is a well-known plant of the Apiaceae family and is 
used in Turkish folk medicine. Infusions of the aerial and 
root parts are used as an antitussive, diuretic, appetizer, 
stimulant, and aphrodisiac [14-16]. E. creticum has been 
used in folk medicine in Jordan as a remedy for scorpion 
stings in the rural areas and as a hypoglycemic agent [17]. E. 
elegans Cham. & Schltdl. was reported to be used for diu-
retic uses in Argentina [18], and E. foetidum for the treat-
ment of several anti-inflammatory disorders in China [19]. 
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Several Eryngium species are used as medicine by various 
tribes of Native Americans. Whole plants of E. alismifolium 
are used for diarrhea; roots of E. aquaticum are used as 
emetic and gastrointestinal infusion, antidote for poisons, 
tapeworms and pinworms, diuretic, and venereal diseases; 
and roots of E. yuccifolium Michx. are used as snakebite and 
toothache remedy as well as for neuralgia, bladder and kid-
ney troubles; roots of E. yuccifolium var. synchaetum are 
used for human and animal sickness such as digestive prob-
lems, diarrhea, headache, body soreness, and snakebites [20]. 
Some recent bioactivity investigations have confirmed some 
traditional medicinal uses. Ethanol extracts of E. billardieri 
Delar., E. campestre, E. creticum, E. davisii, E. foetidum, E. 
isauricum, E. kotschyi, E. maritimum, and E. trisectum 
showed apparent anti-inflammatory and antinociceptive ac-
tivity [21-23]. The fresh leaf extract of E. creticum gave a 
higher percentage inhibition of the haemolytic activity of the 
scorpion venom compared with the dried leaf extract, but 
extracts of both fresh and dried roots of E. creticum gave 
100% inhibition of the snake and scorpion venoms [24]. 
Also, some species (i.e., E. caucasicum) showed antioxidant 
activity [25, 26]. 
To date, terpenoids, triterpenoid saponins, flavonoids, 
coumarins, polyacetylenes, steroids, and essential oils have 
been reported in the genus Erygnium. However, most species 
of Eryngium have not been extensively investigated in 
chemical constituents. Existing phytochemical investigations 
indicated the presence of essential oils (primarily sesquiter-
penes and monoterpenes) in E. bourgatii Gouan (E. amethys-
tinum Lam.), E. billardieri, E. bourgatii Gouan, E. bungei 
Boiss., E. caeruleum M. Bieb., E. campestre, E. cornicula-
tum, E. creticum, E. foetidum, E. giganteum M. Bieb., E. 
glaciale Boiss., E. palmatum Vis. et Pani, E. paludosum 
(Moore et Betche) Michael, E. paniculatum Cav. & Domb. 
ex Delar., E. rosulatum Michael, E. serbicum Pani, E. 
vesiculosum Labill., and E. yuccifolium [25, 27-48]. Other 
classes of compounds isolated from Eryngium include fla-
vonoids from E. campestre, E. giganteum, E. macrocalyx 
Schrenk, E. maritimum, E. octophyllum Eug. Kor., and E. 
yuccifolium [10, 49-54], coumarins from E. campestre and E. 
ilicifolium Lam. [55-57], sterols from E. foetidum and E. 
agavifolim [21], a rosmarinic acid derivative from E. al-
pinum L. [13], lactone from E. carlinae Delar. [58], and 
triterpenoid glycosides from E. bourgatii, E. bromeliifolium 
Delar., E. campestre, E. giganteum, E. macrocalyx, E. mari-
timum, E. octophyllum, E. planum, and E. yuccifolium [10, 
14, 15, 59-66]. The main saponins from this genus belong to 
polyhydroxylated triterpenoid glycosides with ester func-
tions. This class of saponin has been found in various groups 
of plants such as Aesculus chinensis L. (Hippocastanaceae) 
[67-71], Pittosporum tobira (Thunb.) Ait. (Pittosporaceae) 
[72], Sanicula elata var. chinensis Makino (Apiaceae) [73], 
and Harpullia austro-caledonica Baill. (Sapindaceae) [74]. 
This type of saponin has been shown to possess anti-
inflammatory property [71, 75, 76], anti-HIV-1 protease ac-
tivity [68], and cytotoxicity for tumor cells [72, 77-79]. Re-
cently, we isolated and identified 25 new polyhydroxylated 
triterpenoid saponins from North American Aesculus pavia 
L. [77, 80]. The saponins with two acyl groups at C-21 and 
C-22 had cytotoxic activity against 60 cell lines from nine 
different human cancers [77, 81].  
This review focuses on phytochemistry and pharmacol-
ogical activities of 127 compounds isolated and identified 
from Eryngium, particularly non-essential oil compounds 
such as terpenoids, triterpenoid saponins, flavonoids, cou-
marins, polyacetylenes, and steroids. This involves 23 spe-
cies belonging to 9-11 sections of Eryngium in both Old and 
New Worlds (Table 1).  
PHYTOCHEMISTRY 
Of 250 species of the genus Eryngium, only 23 species 
have been more or less investigated phytochemically. To 
date, at least 127 compounds, primarily phenolic compounds 
and terpenoids have been isolated and identified from these 
species, including triterpenoid saponins, monoterpene, ses-
quiterpenes, triterpenoids, flavonoids, coumarins, steroids, 
acetylenes, and other classes of compounds. A summary of 
the compounds isolated from Eryngium species is carried in 
Tables 2 and 3. 
Triterpenoid Glycosides 
The genus Eryngium is known to contain triterpenoid 
saponins as the main components. To date, 25 saponins have 
been isolated from this genus. The most of Eryngium sapon-
ins belong to polyhydroxylated oleanene triterpenoid sapon-
ins (Table 2). This class of saponins has been found in a 
wide range of plants belonging to different families, such as 
Aesculus L. (Hippocastanaceae) [100], Pittosporum tobira 
(Thunb.) Ait. (Pittosporaceae), and Harpullia austro-
caledonica Baill. (Sapindaceae) [10]. In the family Apiaceae, 
Hydrocotyle L., Hacquetia Neck ex DC., Steganotaenia 
Hochst, and Sanicula L. have already indicated the present 
of polyhydroxylated triterpenoid saponins [14].  
Recently, three detailed phytochemical investigation on 
the roots of E. campestre [14, 15] and the whole plant of E. 
yuccifolium [10] resulted in the isolation and structural elu-
cidation of 19 new polyhydroxylated oleanene triterpenoid 
saponins, named 3-O--L-rhamnopyranosyl-(12)--D-
glucuronopyranosyl-22-O-,-dimethylacryloyl-A1-
barrigenol (1), 3-O--L-rhamnopyranosyl-(12)--D-glu-
curonopyranosyl-22-O-angeloyl-R1-barrigenol (2), 3-O--L-
rhamnopyranosyl-(12)--D-glucuronopyranosyl-21-O-
acetyl-22-O-angeloyl-R1-barrigenol (3), 3-O--L-rhamno-
pyranosyl-(12)--D-glucuronopyranosyl-21-O-acetyl-22-
O-,-dimethylacryloyl-R1-barrigenol (4), 3-O--L-
rhamnopyranosyl-(12)--D-glucuronopyranosyl-22-O-an-
geloyl-28-O-acetyl-R1-barrigenol (5), 3-O--D-glucopy-
ranosyl-(12)-[-L-rhamnopyranosyl-(14)]--D-glucuro-
nopyranosyl-22-O-angeloyl-R1-barrigenol (6), 3-O--D-
glucopyranosyl-(12)-[-L-rhamnopyranosyl-(14)]--D-
glucuronopyranosyl-22-O-,-dimethylacryloyl-A1-barrige-
nol (7), eryngiosides A-L (8-19), together with two know 
saponins 21-angeloyloxy-3-[-D-glucopyranosyl-(12)]-
[-D-xylopyranosyl-(13)]--D-glucuronopyranosyloxyol-
ean-12-ene-15, 16, 22, 28-tetrol (20) and sani-
culasaponin III (21).  
Four triterpenoids R1-barrigenol (28), A1-barrigenol (29), 
barringtogenol C (31), and 3, 16, 22, 28-
tetrahydroxyolean-12-ene derivatives were recognized to be 
the aglycones of polyhydroxylated Eryngium saponins with 
acyl functions at C-21 and C-22 positions. The Eryngium 
saponins resemble that of Aesculus species, but there were 
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various differences between both saponins in aglycons and 
sugar components. Especially, all saponins identified from E. 
campestre are interesting structurally because the acylation 
by a ,-dimethylacrylic acid or angeloyl at the C-22 posi-
tion is rare among triterpenoid saponins [14]. Eryngium 
saponins from E. yuccifolium are characterized as an ange-
loyl (Ang) attached to C-21 or C-22, and an angeloyl 
(Ang)/acetyl (Ac) group to the C-21/22 positions. The 
saponins structurally based on three aglycones of R1-
barrigenol (28), A1-barrigenol (29), barringtogenol C (31) 
with the hydroxyl group at C-15 and/or C-21 contained one 
oligosaccharide chain with a glucuronopyranosyl unit at-
tached to C-3 position of the aglycones. This oligosaccharide 
chain had a rhamnopyranosyl or an arabinopyranosyl unit 
attached to the glucuronopyranosyl unit. The saponins pos-
sessed the aglycone of 3, 16, 22, 28-tetrahydroxyolean-
12-ene without a hydroxyl group at C-15 and C-21 linked a 
trisaccharide chain of glucoses and galacoses to the C-3 po-
sition. However, these saponins were identified bearing none 
of acyl functions at C-21 and C-22. It was believed that at 
least one angeloyl moiety at either C-21 or C-22 positions of 
Eryngium saponins by a recent structure–activity relationship 
(SAR) investigation makes significant contribution to the 
cytotoxicities, but the type and number of sugar moiety at C-
3 may decrease their cytotoxicities [101]. 
Some other classes of triterpenoid saponins were also re-
ported in Eryngium species. 3-O--D-glucopyranosyl 
oleanolic acid 28-O--D-xylopyranoside (22) and 3-O-[-D-
glucopyranosyl-(12)-[-D-fucopyranosyl-(13)]--L-
rhamnopyranosyl-(14)--D-glucopyranosyl]-olean-12-en-
Table 1. List of Eryngium Species Included in this Review. 
Section Species  Reference 
OLD WORLD   
E. alpinum L. [13] Section Alpina 
E. giganteum M. Bieb. (synonyms: E. asperifolium F. Delar., E. glau-
cum Hoffm.) 
[13, 46, 54] 
E. bourgatii Gouan (synonyms: E. alpinum Lapeyr., E. amethystinum 
Lam., E. pallescens Mill., E. planum Lapeyr., E. tounefortii Bubani) 
[13, 46, 82-84] 
 
Section Campestria 
E. campestre L. (synonyms: E. latifolium Hoffm. & Link ex Willk & 
Lange, E. officinale Garsault, E. trifidum L.)  
[14, 15, 45, 50, 52, 55, 85] 
E. ilicifolium Lam. [56] Section Dryophylla 
E. octophyllum Korovin (synonyms: E. mirandum Bobrov) [51, 66] 
E. macrocalyx Schrenk (synonym: E. incognitum Paviov) [65, 86, 87] Section Halobia 
E. maritimum L. (synonym: E. marinum Garsault) [46, 49, 63, 88] 
Section Palmito E. serbicum Pani [82] 
E. caucasicum Trautv. (synonyms: E. biebersteinianum Nevski) [66, 89] 
 
E. creticum Lam. (synonyms: E. cyaneum Sm., E. syriacum Lam.) [25, 90, 91] 
E. dichotomum Desf. [53, 92] 
E. planum L. (synonyms: E. E. armatum Csató ex Simonk., E. caer-
uleum M. Bieb., E. dalla-torrei M. Hiroe, E. intermedium Weinm.), E. 
latifolium Gilib., E. planifolium Pall., E. planum Lindl., E. planum var. 
armatum Csató ex Simonk., E. pumilum Gilib., E. pusillum Gilib.) 
[13, 46, 86, 93-98] 
 
E. variifolium Coss. [13, 46] 
Section Plana 
 
E. spinalba L. (synonyms: E. rigidum Lam., E. leucacanthum St.-Lag.) [13] 
Section (unknown) E. tripartitum Desf.  [13] 
NEW WORLD   
Section Areata E. agavifolium Griseb.  [13] 
Section Foetida E. foetidum L. (synonyms: E. antihystericum Rottler, E. antihystericum 
Rottb.) 
[21, 59, 99] 
Section (unknown) E. bromeliifolium Delar. [60-62] 
E. eburneum Decne. (synonyms: E. bracteosum (DC.) Griseb., E. pani-
culatum var. bracteosum DC.)  
[13] 
E. pandanifolium Cham. & Schltdl. (synonyms: E. decaisneanum Urb., 
E. oligodon (DC.) Griseb., E. pandanifolium var. atrocephalum 
Kuntze), E. paniculatum var. oligodon DC.)  
[13] 
E. paniculatum Cav. & Domb. Ex Delar. (synonyms: E. paniculatum 
var. chinense DC., E. paniculatum f. junior Urb., E. paniculatum var. 
litorale G. Kunkel, E. subulatum Vell.) 
[47] 
Section Panniculata 
E. yuccifolium Michx. [10, 13, 27] 
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Table 2. Major Non-Essential oil Compounds Isolated and Identified from Eryngium 
No. Compound Name Botanical Source Reference 
 Triterpenoid Saponins   
1 3-O--L-rhamnopyranosyl-(12)--D-glucuronopyranosyl-22-O-,-
dimethylacryloyl-A1-barrigenol 
E. campestre [15] 
2 3-O--L-rhamnopyranosyl-(12)--D-glucuronopyranosyl-22-O-
angeloyl-R1-barrigenol  
E. campestre [15] 
3 3-O--L-rhamnopyranosyl-(12)--D-glucuronopyranosyl-21-O-acetyl-
22-O-angeloyl-R1-barrigenol  
E. campestre [15] 
4 3-O--L-rhamnopyranosyl-(12)--D-glucuronopyranosyl-21-O-acetyl-
22-O-,-dimethylacryloyl-R1-barrigenol  
E. campestre [15] 
5 3-O--L-rhamnopyranosyl-(12)--D-glucuronopyranosyl-22-O-
angeloyl-28-O-acetyl-R1-barrigenol 
E. campestre [15] 
6 3-O--D-glucopyranosyl-(12)-[-L-rhamnopyranosyl-(14)]--D-
glucuronopyranosyl-22-O-angeloyl-R1-barrigenol 
E. campestre [14] 
7 3-O--D-glucopyranosyl-(12)-[-L-rhamnopyranosyl-(14)]--D-
glucuronopyranosyl-22-O-,-dimethylacryloyl-A1-barrigenol 
E. campestre [14] 
8 eryngiosides A E. yuccifolium  [10] 
9 eryngiosides B E. yuccifolium  [10] 
10 eryngiosides C E. yuccifolium  [10] 
11 eryngiosides D E. yuccifolium  [10] 
12 eryngiosides E E. yuccifolium  [10] 
13 eryngiosides F E. yuccifolium  [10] 
14 eryngiosides G E. yuccifolium  [10] 
15 eryngiosides H E. yuccifolium  [10] 
16 eryngiosides I E. yuccifolium  [10] 
17 eryngiosides J E. yuccifolium  [10] 
18 eryngiosides K E. yuccifolium  [10] 
19 eryngiosides L E. yuccifolium  [10] 
20 21-angeloyloxy-3-[-D-glucopyranosyl-(12)]-[-D-xylopyranosyl-
(13)]--D-glucuronopyranosyloxyolean-12-ene-15, 16, 22, 28-
tetrol  
E. yuccifolium  [10] 
21 saniculasaponin III  E. yuccifolium  [10] 
22 3-O--D-glucopyranosyl oleanolic acid 28-O--D-xylopyranoside  E. bromeliifolium  [60] 
23 3-O-[-D-glucopyranosyl-(12)-[-D-fucopyranosyl-(13)]--L-
rhamnopyranosyl-(14)--D-glucopyranosyl]-olean-12-en-23,28-diol 
E. foetidum  [59] 
24 betulinic acid 3-O--D-glucopyranoside E. bromeliifolium [62] 
25 betulinic acid-3-O--D-glucopyranosyl(16)--D-glucopyranoside E. bromeliifolium [61] 
 Triterpenoids   
26 betulinic acid E. bromeliifolium [64] 
27 oleanolic acid E. macrocalyx (E. incognitum) [65, 87] 
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Table 2. Contd…. 
No. Compound Name Botanical Source Reference 
28 R1-barringenol E. maritimum  
E. planum 
E. caucasicum (E. biebersteini-
anum) 
E. octophyllum 
[63, 66, 95] 
29 A1-barringenol  E. maritimum  
E. planum 
E. caucasicum (E. biebersteini-
anum) 
E. octophyllum 
[63, 66, 95] 
30 22-(2-methyl-2-butenoate)-olean-12-ene-3,15,16,22,28-pentol E. macrocalyx [65] 
31 barringtogenol C E. maritimum 
E. planum 
[63, 95] 
32 erynginol A E. planum [95] 
33 22-hydroxyerythrodiol E. maritimum [63] 
 Sesquiterpenes   
34 eryng-9-en-15-al E. creticum [25] 
35 15-hydroxy--muurolene E. giganteum [46] 
36 15-oxy--muurolene E. giganteum [46] 
37 15-nor--muurolene E. giganteum [46] 
38 (+)-ledol E. giganteum  [46] 
39 (+)-spathulenol E. giganteum  [46] 
40 germacrene D E. giganteum  [46] 
41 trans--farnesene E. giganteum  [46] 
 Monoterpenes   
42 3-(-D-glucopyranosyloxymethyl)-2,4,4-trimethyl-2,5-cyclohexadien-1-
one 
E. campestre 
E. creticum 
[45, 91] 
43 3-(-D-glucopyranosyloxymethyl)-2,4,4-trimethyl-2-cyclohexen-1-one E. campestre [45] 
44 5-[(-D-glucopyranosyloxy)methyl]-4-hydroxy-4-[(1E,3S)-3-hydroxy-1-
butenyl]-3,5-dimethyl-2-cyclohexen-1-one, 
E. dichotomum [53] 
45 isoferulyl senecioate E. variifolium [46] 
46 (-)-2,4,4-trimethyl-3-formyl-2,5-cyclohexadienyl angelate E. paniculatum [47] 
47 O-[2-angeloyloxymethyl-cis-crotonoyl]-ferulol E. bourgatii (E. amethystinum) 
E. serbicum 
[82] 
48 O-[2-angeloyloxymethyl-cis-crotonoyl]-isoferulol E. bourgatii (E. amethystinum) 
E. serbicum 
[82] 
49 O-[2-(2-methyl-butyryloxymethyl)-cis-crotonoyl]-ferulol E. bourgatii (E. amethystinum) 
E. serbicum 
[82] 
50 O-[2-(2-methyl-butyryloxymethyl)-cis-crotonoyl]-isoferulol E. bourgatii (E. amethystinum) 
E. serbicum 
[82] 
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Table 2. Contd…. 
No. Compound Name Botanical Source Reference 
51 O-[2-isovaleryloxymethyl)-cis-crotonoyl]-isoferulol E. bourgatii (E. amethystinum) 
E. serbicum 
[82] 
 Flavonoids   
52 quercetin E. creticum [91] 
53 quercitrin E. campestre [52] 
54 isoquercitrin E. campestre 
E. maritimum 
E. giganteum 
[49, 52, 54] 
55 rutin E. campestre 
E. octophyllum 
[51, 52] 
56 luteolin 7-O--D-glucopyranoside E. campestre [52] 
57 astragalin E. campestre 
E. maritimum 
[49, 52, 54] 
58 kaempferol 7-O--L-rhamnopyranoside E. campestre [52] 
59 kaempferol 3--D-glucopyranosyl-7-O--L-rhamnopyranoside E. maritimum 
E. macrocalyx 
[49, 51] 
60 kaempferol 3,7-di-O--L-rhamnopyranoside E. campestre 
E. planum 
E. giganteum 
[52, 54, 97, 98] 
61 kaempferol-3-O-(6-O--D-glucopyranosyl)--D-galactopyranoside E. planum [96] 
62 kaempferol 3-O--D-(2-p-E-hydroxycinnamoyl) -glucopyranoside E. campestre [50] 
63 kaempferol 3-O--D-(2-p-Z-hydroxycinnamoyl)- glucopyranoside E. campestre [50] 
64 kaempferol-3-O-(2-O-trans-p-methoxycoumaroyl-6-O-trans-p-
coumaroyl)--D-glucopyranoside 
E. yuccifolium [10] 
65 kaempferol-3-O-(2,6-di-O-trans-p-coumaroyl)- 
-D-glucopyranoside 
E. yuccifolium [10] 
66 naringenine 7-O--L-rhamnopyranosyl-(12)-O--D-glucopyranoside E. dichotomum [53] 
 Coumarins   
67 umbelliferon E. biebersteinianum [89] 
68 scopoletin E. bourgatii [84] 
69 6,7-dimethoxycoumarin E. creticum [90] 
70 bergaptin E. biebersteinianum [89] 
71 decursinol E. biebersteinianum [89] 
72 prantschimgin E. ilicifolium [56] 
73 deltoin  E. creticum [56, 91] 
74 (+)-marmesin E. creticum 
E. ilicifolium 
[56, 91] 
75 aegelinol benzoate E. campestre [55] 
Table 2. Contd…. 
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No. Compound Name Botanical Source Reference 
76 agasyllin E. campestre [55] 
77 grandivittin E. biebersteinianum [55, 89] 
78 aegelinol E. campestre [55] 
 Phenolics   
79 1--D-Glucopyranosyloxy-3-methoxy-5-hydroxybenzene E. creticum [91] 
80 3,4-dihydroxyphenyl caffeate E. yuccifolium [10] 
81 (4--D-glucopyranosyloxy)-3-hydroxyphenyl caffeate E. yuccifolium [10] 
82 R-(+)-rosmarinic acid E. alpinum [13] 
83 R-(+)-3'-O--D-glucopyranosyl rosmarinic acid E. alpinum 
E. bourgatii (E. amethystinum) 
E. maritimum 
E. campestre  
[13] 
84 caffeic acid E. yuccifolium [10] 
85 chlorogenic acid E. alpinum [13] 
 Steroids   
86 -sitosterol  E. foetidum [21, 91, 99] 
87 -sitosterol 3-O--D-glucopyranoside E. creticum [91] 
88 stigmasterol E. foetidum [21, 92, 99] 
89 stigmasterol 3-O--D-glucopyranoside E. dichotomum [92] 
90 campesterol E. foetidum  [21] 
91 brassicasterol E. foetidum  
E. agavifolium 
[21, Supporting Data I] 
92 3-cholesterol E. foetidum  [21] 
93 (-)-clerosterol E. foetidum  [21] 
94 5-avenosterol E. foetidum  [21] 
95 5-avenasterol E. foetidum  [21] 
96 5, 24-stigmastadienol E. foetidum  [21] 
 Acetylenes   
97 falcarinone E. yuccifolium 
E. bourgatii 
[27, 83, 84]  
98 falcarinolone E. bourgatii [84] 
99 falcarinol E. yuccifolium 
E. bourgatii 
[27, 84] 
100 yuccifolol E. yuccifolium [27] 
101 1,8-heptadecadiene-4,6-diyne-3,9-diol E. yuccifolium [27] 
102 (8E)-1,8-Heptadecadiene-4,6-diyne-3,10-diol  E. agavifolium  [Supporting Data I] 
103 (Z)-15-hydroxy-9,16-Heptadecadiene-11,13-diyn-8-one  E. agavifolium  [Supporting Data I]] 
104 (E)-15-hydroxy-9,16-Heptadecadiene-11,13-diyn-8-one  E. agavifolium  [Supporting Data I] 
105 (Z)-6-pentyl-2-[2-oxobutin-(3)-yliden]tetrahydropyran E. bourgatii  [83, 84] 
106 (E)-6-pentyl-2-[2-oxobutin-(3)-yliden]tetrahydropyran E. bourgatii  [84] 
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Table 3. Other non-Essential oil Compounds Isolated and Identified from Eryngium 
No. Name Botanical Source Reference 
107 2,3,4-trimethylbenzaldehyde E. varrifolium 
E. bourgatii (E. amethystinum)  
E. serbicum 
[46, 82] 
108 2,3,6-trimethylbenzaldehyde E. varrifolium 
E. bourgatii (E. amethystinum)  
E. serbicum 
[82] 
109 cis-chrysanthenyl acetate E. planum [46] 
110 cis-chrysanthenyl hexanoate  E. planum [93] 
111 cis-chrysanthenyl octanoate E. planum [93] 
112 2-angeloyloxymethyl-cis-crotonic acid methyl ester E. bourgatii (E. amethystinum)  
E. serbicum 
[82] 
113 2-(2-methyl-butyryloxymethyl)-cis-crotonic acid methylester E. bourgatii (E. amethystinum)  
E. serbicum 
[82] 
114 2-isovaleryloxymethyl-cis-crotonic acid methylester E. bourgatii (E. amethystinum)  
E. serbicum 
[82] 
115 10-hentriacontanone E. maritimum [46] 
116 eicosa-8,11-dien-18-ol-2-one E. creticum [25] 
117 hexadecanoic acid  E. agavifolium [Supporting Data I] 
118 (9Z,11Z)-9,11-octadecadienoic acid, methyl ester  E. agavifolium [Supporting Data I] 
119 (7Z)-7-hexadecen-1-ol, 1-acetate  E. agavifolium [Supporting Data I] 
120 1-kestose E. planum [94] 
121 sucrose E. dichotomum [53, 94] 
122 2-O-methyl--D-fructofuranose E. dichotomum [53] 
123 D-glucose  E. planum [94] 
124 D-furanose E. dichotomum [53, 94] 
125 D-mannitol E. dichotomum 
E. creticum 
E. campestre 
E. caeruleum  
E. macrocalyx 
[53, 91] [85] [86] 
126 D-galactitol E. creticum [91] 
127 piperidine-2-carboxylic acid E. maritimum [88] 
 
23,28-diol (23) were isolated and identified from E. bromeli-
ifolium [60] and E. foetidum [59]. Two glucopyranosyl gly-
cosides of betulinic acid with monosaccharide (24) and di-
saccharide unit (25) attached to C-3 were also obtained from 
E. bromeliifolium [61, 62]. 
Terpenoids 
Triterpenoids 
A total of 8 triterpenoids were isolated and identified 
from the acid and alkaline hydrolysates of Eryngium saponin 
in a few early investigations (Table 2). All belong to penta-
cyclic triterpenoids, which are classified as two series of 
olean-12-ene and lupine. It is noted that olean-12-ene deriva-
tives are characterized by having multiple hydroxyl groups at 
C-3, 15, 16, 21, 22, and 28 positions, rarely at C-29 position. 
These triterpenoids included betulinic acid (26) from E. bro-
meliifolium [64], oleanolic acid (27) from E. macrocalyx (E. 
incognitum) roots [65, 87], R1-barringenol (28) and A1-
barringenol (29) from the aerial flowering plant parts of E. 
maritimum [63], E. planum leaves and roots [95], and the 
underground parts of E. caucasicum (E. biebersteinianum) 
and E. octophyllum [66], 22-(2-methyl-2-butenoate)-olean-
12-ene-3,15,16,22,28-pentol (30) from E. macrocalyx [65], 
erynginol A (32) from E. planum leaves [95], barringtogenol 
C (31) and 22-hydroxyerythrodiol (33) from E. maritimum 
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[63]. Barringtogenol C (31) was also identified being a major 
component from E. planum leaves [95].  
Sesquiterpenes 
Four perhydronaphthaline derivatives (Table 2) substi-
tuted with one n-propyl were isolated and identified from the 
hexane/ether extracts of the aerial parts of E. creticum grow-
ing in Sinai, Egypt [25] and the etheral extracts of the seeds 
of E. giganteum [46]. The other four sesquiterpenes reported 
to naturally occur in various essential oils were isolated from 
the etheral extracts of the seeds of E. giganteum [46]. These 
sesquiterpenes are eryng-9-en-15-al (34), 15-hydroxy--
muurolene (35), 15-oxy--muurolene (36), 15-nor--
muurolene (37), (+)-ledol (38), (+)-spathulenol (39), ger-
macrene-D (40), trans--farnesene (41).  
1   R1=H, R2=dMA, R3=H, R4=-L-rhamnopyranosyl, R5=H
2   R1=OH, R2=Ang, R3=H, R4=-L-rhamnopyranosyl, R5=H
3   R1=OAc, R2=Ang, R3=H, R4=-L-rhamnopyranosyl, R5=H
4   R1=OAc, R2=dMA, R3=H, R4=-L-rhamnopyranosyl, R5=H
5   R1=OH, R2=Ang, R3=Ac, R4=-L-rhamnopyranosyl, R5=H
6   R1=OH, R2=Ang, R3=H, R4=-D-glucopyranosyl, R5=-L-rhamnopyranosyl
7   R1=H, R2=dMA, R3=H, R4=-D-glucopyranosyl, R5=-L-rhamnopyranosyl
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Monoterpens 
Three monoterpene glycosides of the cyclohexanone type 
and seven monoterpene aldehyde-esters were identified from 
seven Eryngium species (Table 2). They are include 3-(-D-
glucopyranosyloxymethyl)-2,4,4-trimethyl-2,5-
cyclohexadien-1-one (42) from E. campestre [45] and E. 
creticum, which grows wildly in Jordan [91], 3-(-D-
glucopyranosyloxymethyl)-2,4,4-trimethyl-2-cyclohexen-1-
one (43) from E. campestre [45], 5-[(-D-glucopy-
ranosyloxy)methyl]-4-hydroxy-4-[(1E,3S)-3-hydroxy-1-
butenyl]-3,5-dimethyl-2-cyclohexen-1-one (44) from the 
aerial parts of E. dichotomum from Tunisian [53], isoferulyl 
senecioate (45) from leaves of E. variifolium [46], (-)-2,4,4-
trimethyl-3-formyl-2,5-cyclohexadienyl angelate (46) from 
seeds of E. paniculatum [47], O-[2-angeloyloxymethyl-cis-
crotonoyl]-ferulol (47), O-[2-angeloyloxymethyl-cis-croto-
noyl]-isoferulol (48), O-[2-(2-methyl-butyryloxymethy-l)-
cis-crotonoyl]-ferulol (49), O-[2-(2-methyl-butyryloxymet-
hyl)-cis-crotonoyl]-isoferulol (50), and O-[2-isovaleryloxy-
R6
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R4
27  R1=H, R2=H, R3=H, R4=H, R5=COOH, R6=CH3
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31  R1=H, R2=OH, R3=OH, R4=OH, R5=CH2OH, R6=CH3
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COOH
RO
24 R=-D-glucopyranosyl
25 R=-D-glucopyranosyl-(16)--D-glucopyranosyl
26 R=H
CH2OH
O
CH2OH
23
O
HO
OH
OH
O
O
OO
H3C
HO
O
OH
HO
OH
OH
O
OHHO
HO
H3C
Ang=Angeloyl
O
dMA=,-dimethylacryloyl Ac=Acetyl
O
O
O
OH
OH
H3C
HO
O
OH
OH
HO
HO
-L-rhamnopyranosyl -D-glucopyranosyl
CHO
34
R
H
H 35 R= CH2OH
36 R=CHO
37 R= H
CH3
OHH3C
H
H
H3C
CH3
H
H
H3C CH3
HO
CH3
38 39 40
41
H
H
O
O
OH
OH
O
OH
OH
OH
HO
O
O
O
HO
OH
HO
HO
O
O
O
HO
OH
HO
HO
42
43 44
 
 
Phytochemical Constituents and Pharmacological Activities Pharmaceutical Crops, 2012, Volume 3   109 
methyl-cis-crotonoyl]-isoferulol (51) from the roots of E. 
bourgatii (E. amethystinum) and E. serbicum [82].  
Phenolic Compounds 
Flavonoids 
Flavonoids are also one of the main components of the 
genus Eryngium. A total of 15 flavonoids including fla-
vonols (52-65), and flavanone (66) were isolated and identi-
fied from Eryngium species (Table 2). The glycosides of 
quercetin (52) [91] and kaempferal with an oligosaccharide 
chain at C-3 or C-7, or two oligosaccharide chains at C-3 and 
C-7 are types of flavonol glycosides. 
Chemical investigation on the aerial parts of E. cam-
pestre resulted in the isolation and structural determination 
of 8 flavonol glycosides [50, 52]. These compounds are 
quercitrin (53), isoquercitrin (54), rutin (55), astragalin (57), 
kaempferol 7-O--L-rhamnopyranoside (58), kaempferol 
3,7-di-O--L-rhamnopyranoside (60), Kaempferol 3-O--D-
(2'-p-E-hydroxycinnamoyl)-glucopyranoside (62), and kaem-
pferol 3-O--D-(2'-p-Z-hydroxycinnamoyl)-glucopyranoside 
(63). Kaempferol 3--D-glucopyranosyl-7-O--L-rhamno-
pyranoside (59), astragalin, and isoquercitrin was identified 
as the major flavonoid constituents from the aerial parts of E. 
maritimum [49]. Three investigations led to the isolation and 
identification of two flavonoid glycosides Kaempferol-3-O-
(6-O--D-glucopyranosyl)--D-galactopyr-anoside (61) and 
60 from the leaves of E. planum [96-98]. A new compound, 
kaempferol-3-O-(2-O-trans-p-methoxycou-maroyl-6-O-trans-
p-coumaroyl)--D-glucopyranoside (64), and a known fla-
vonoid glycoside kaempferol-3-O-(2,6-di-O-trans-p-cou-
maroyl)--D-glucopyranoside (65) were recently isolated 
and identified from the whole plants of E. yuccifolium [10]. 
Additionally, Compound 55 was also found from the aerial 
parts of E. octophyllum [51], compound 59 from the aerial 
parts of E. macrocalyx [51], and compounds 54 and 60 from 
the leaves of E. giganteum [54].  
Luteolin 7-O--D-glucopyranoside (56) and naringenine 
7-O--L-rhamnopyranosyl-(12)-O--D-glucopyranoside 
(66) were also identified from E. campestre [52] and the 
aerial parts of E. dichotomum [53].  
Coumarins 
Simple coumarins and linear furanocoumarins were also 
found from Eryngium species (Table 2). These coumarins 
are scopoletin (68) from the roots of E. bourgatii [84]; 6,7-
dimethoxycoumarin (69), deltoin (73), and (+)-marmesin 
(74) from E. creticum [90, 91]; umbelliferon (67), bergaptin 
(70), decursinol (71), grandivittin (77) from E. biebersteini-
anum [89]; prantschimgin (72), deltoin, and (+)-marmesin 
from Et2O extracts of E. ilicifolium [56]; and aegelinol ben-
zoate (75), agasyllin (76), aegelinol (78), and grandivittin 
from the roots of E. campestre [55].  
Other Phenolic Compounds 
1--D-glucopyranosyloxy-3-methoxy-5-hydroxybenzene 
(79) was yielded from E. creticum, which grows wildly in 
Jordan [91]. Three phenolic compounds, including two new 
phenyl caffeates, 3,4-dihydroxyphenyl caffeate (80) and (4-
-D-glucopyranosyloxy)-3-hydroxyphenyl caffeate (81), 
together with known compound caffeic acid (84) were iso-
lated and identified from E. yuccifolium [10].  
In addition, the isolation of antioxidative substances from 
the root extracts of E. alpinum allowed the identification of 
R-(+)-3'-O--D-glucopyranosyl rosmarinic acid (83), a new 
rosmarinic acid derivative, together with two known com-
pounds R-(+)-rosmarinic acid (82), and chlorogenic acid (85) 
[13]. Moreover, R-(+)-3'-O--D-glucopyranosyl rosmarinic 
acid (83) was found that is unstable in a MeOH/H2O (1/1, 
v/v) solution, of which one-third quantity was degraded after 
11 h at room temperature. In the chemotaxonomic study ana-
lyzed by HPLC, R-(+)-rosmarinic acid and R-(+)-3'-O--D-
glucopyranosyl rosmarinic acid were detected in all analyzed 
13 Eryngium species, except E. giganteum, which was de-
void of R-(+)-3'-O--D-glucopyranosyl rosmarinic acid, and 
distinct concentration variations of 83 were observed in E. 
bourgatii (E. amethystinum), E. maritimum, and E. cam-
pestre [13].  
Steroids 
Eleven steroids have been identified from Eryngium spe-
cies (Table 2). These compounds include -sitosterol (86), 
stigmasterol (88), campesterol (90), brassicasterol (91), 3-
cholesterol (92), (-)-clerosterol (93), 5-avenosterol (94), 
7-avenasterol (95), and 5,24-stigmastadienol (96) from 
the hexane extracts of the leaves of E. foetidum [21, 99]. 
Brassicasterol (91) was also isolated and identified from the 
EtOH extract of the whole plant of E. agavifolium (Support-
ing Data I). A comparison study indicated that all of steroids 
in the leaves presented also in the stems with different quan-
tities [99]. Stigmasterol, -sitosterol, and their glycosides (87 
and 89) were isolated and identified from the aerial parts of 
E. dichotomum grown in Tunisia [92] and E. creticum grow-
ing wildly in Jordan [91], respectively.  
Acetylenes 
Eryngium contains also polyacetylenes (Table 2). Yucci-
folol (nonadeca 1,11-diene 4,6,8-triyne 3,10-diol, 100), a 
novel polyacetylene, was isolated and identified from the 
hexane/ether extracts of the aerial parts of E. yuccifolium, 
together with the known polyacetylenes, falcarinone (97), 
falcarinol (99) and heptadeca 1,8-diene 4,6-diyne 3,9-diol 
(101) [27]. (8E)-1,8-heptadecadiene-4,6-diyne-3,10-diol 
(102), (Z)-15-hydroxy-9,16-heptadecadiene-11,13-diyn-8-
one (103), and (E)-15-hydroxy-9,16-heptadecadiene-11,13-
diyn-8-one (104) were isolated from the EtOH extract of the 
whole plant of E. agavifolium (Supporting Data I). The roots 
of E. bourgatii afforded, in addition, to falcarinone, falcari-
nolone (98), and falcarinol, the Z and E isomers of 6-pentyl-
2-[2-oxobutin-(3)-yliden]tetrahydropyran (105 and 106). The 
new Z isomer of 6-pentyl-2-[2-oxobutin-(3)-yliden]tetrahy-
dropyran is unstable as it easily converts into the E isomer 
[83, 84].  
Miscellaneous 
There are 18 other classes of compounds obtained from 
some species of Eryngium L. (Table 3) These compounds 
include two trimethylbenzaldehydes (107 and 108) from the 
leaves of E. varrifolium [46], E. bourgatii (E. amethystinum) 
and E. serbicum [82], three cis-chrysanthenyl esters (109-
111) from the flowers and seeds of E. planum [46, 93] , three 
2-substituents derivatives of cis-crotonic acid methyl ester 
(112-114) from E. bourgatii (E. amethystinum) and E. ser-
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bicum [82], two long-chain aliphatic ketones (115 and 116) 
from the leaves of E. maritimum [46] and E. creticum [25], 
and three long-chain aliphatic acids (117-119) from the 
EtOH extract of the whole plant of E. agavifolium  
(Supporting Data I). From a chemotaxonomic point of view, 
10-hentriacontanone (115) appears to be a good chemical 
marker of E. maritimum. Analysis of several E. maritimum 
collections of different origins always showed the presence 
of this ketone. However, this metabolite has also been found 
in two other Eryngium species, namely E. bourgatii and E. 
campestre [46].  
In addition, sucrose (121), furanose (124) and its 2-
methyl analog (122) were found from the aerial parts of E. 
dichotomum in Tunisian [53]; D-glucose (123) and a nonre-
ducible trisaccharide, 1-kestose (120), from E. planum roots 
[94]; two polyols, D-mannitol (125) and D-galactitol (126), 
from E. dichotomum [53], E. creticum [91], E. campestre 
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O
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[85], E. caeruleum and E. macrocalyx [86]; and a piperidine-
2-carboxylic acid (127) from E. maritimum [88]. 
BIOLOGICAL AND PHARMACOLOGICAL ACTIVI-
TIES 
The in vitro and in vivo biological activities of Eryngium 
extracts or isolates (including both essential oils and non-
essential oil compounds) are summarized in Tables 4 and 5. 
Cytotoxicities 
Eryngiosides A-C, E, F, H-J, L, 21-angeloyloxy-3-[-
D-glucopyranosyl-(12)]-[-D-xylopyranosyl-(13)]--D-
glucuronopyranosyloxyolean-12-ene-15, 16, 22, 28-
tetrol (20), and Saniculasaponin III isolated from the whole 
plants of E. yuccifolium Michx [10] were evaluated for their 
ability to inhibit human DNA topoisomerase I (TOP1) and II 
(TOP2) activity and cytotoxicity against PANC-1, A549, 
PC-3, HL-60, and MRC-5 cell lines (Table 6). None of eryn-
giosides demonstrated any TOP1 and TOP2 inhibitory ac-
tivities. Three eryngiosides (eryngioside J, eryngioside L, 
and saniculasaponin III) showed moderate cytotoxicity 
against all cell lines after 48 h of incubation. The GI50 values 
vary from 3.54 μM to 16.02 μM. These eryngiosides were 
most effective against human lung cancer cell lines A-549 
and normal cell lines MRC-5, and markedly inhibited the 
growth of pancreas cancer cell lines PANC-1. Eryngium 
saponin 20 also exhibited moderate cytotoxicity against 
A549, PC-3, HL-60, and MRC-5 cell lines with GI50 values 
of 7.34-9.38 μM while no toxicity against the human pan-
creas cancer cells PANC-1 [81]. Especial, Eryngioside H and 
I exhibited potent and highly selective inhibition against four 
OH
OCH3
O
O
HO
HO
OH
HO
O
O
OH
HO
HO
COOH
OH
OH
COOH
O
O
HO
OH
OR
OH
82 R=H
83 R= -D-glucopyranosyl
79
85
O
O
HO
OH
OH
OR
80 R=H
81 R= -D-glucopyranosyl
COOH
HO
OH
84
86 R=H 
87 R=-D-glucopyranosyl
RO
RO
88 R=H 
89 R=-D-glucopyranosyl
HO HO
HO HO
HO
HO
HO
90 91
92 93
94
95 96
 
 
112    Pharmaceutical Crops, 2012, Volume 3 Wang et al. 
human tumor cells but almost no cytotoxicity against normal 
human cells (Figs. 1 and 2, and see Supporting Data II). 
Compounds 1-4, and 7 isolated from the roots of E. cam-
pestre showed a weak cytotoxic activity, with IC50 between 
40 and 100 μg/mL, against HCT 116 and HT-29 human tu-
mor cell lines by MTT assay [15]. 
Ethanol extracts from fruits of E. planum were shown to 
display highly significant in inducing apoptosis in two hu-
man leukemic cell lines C8166 (96%) and J45 (89%) after 24 
h incubation in concentration of 300 μg/mL. Lower level of 
apoptotic cells was observed in HL-60 (49%) and ML-1 
(42%). The tested human leukaemia cell lines included hu-
man acute myeloblastic leukaemia (ML-1), human acute T 
cell leukaemia (J-45.01), human eosinophilic leukaemia 
(EOL), human caucasian promyelocytic leukaemia (HL-60), 
human T cell leukaemia lymphoblast (1301), human T cell 
leukaemia (C-8166), human myeloma (U-266B1), human 
Caucasian normal B cell (WICL), and human T cell (H-9) 
[101].  
Anti-Mutagenic Activity  
An anti-mutagenic potential of E. creticum was evi-
denced on MNNG induced mutagenicity using rat hepato-
cytes. The study was focused on ethanolic extracts, while the 
extracts had no effect on cytotoxicity indicators such as ne-
crosis and apoptosis. The effects obtained can be attributed 
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to a direct antimutagenic activity and an increased recovery 
at the chromosomal level [102]. 
Anti-Inflammatory Activities 
Extracts obtained from the root and aerial parts of various 
Eryngium species are used as folk remedy worldwide for the 
treatment of various inflammatory disorders. Recently, in a 
antiinflammatory activity screening on extracts of 121 plants 
typical for the traditional Mediterranean diet, E. campestre 
L. decreased nitric oxide and TNF-alpha synthesis in the 
murine endothelial cells of monocyte origin activated with 
LPS, decreased cytokine or LPS-stimulated iNOS mRNA 
levels in both cell types [103]. It has been reported that etha-
nol extracts either from the aerial parts or roots of 7 Eryn-
gium species growing in Turkey showed remarkably anti-
inflammatory and antinociceptive activity in mice. Espe-
cially, the aerial parts and roots of E. maritimum and E. 
kotschyi were found to possess most promising activities 
without including any apparent gastric damage [22]. More 
detailed research showed the antiinflammatory effect of E. 
maritimum may be produced by a sub-alkaline fraction [23]. 
Saponin mixtures isolated from E. planum prevented in-
flammatory responses when injected into rats at concentra-
tion of 0.5 mg/kg, but oral administration at same dose had 
no antiinflammatory effect [104]. 
The hexane extracts from the leaves of E. foetidum can 
reduce the edema, induced by 12-0-tetradecanoylphorbol 
acetate (TPA) in the mouse, in a similar proportion in acute 
Table 4. Biological Activities of Eryngium as Revealed by In Vitro Studies 
Bioactivties Description Bioactive Agents Reference 
Exhibited moderate or weak cytotoxicities against human pan-
creas, prostate, lung, leukemic, colon cancer cell lines and nor-
mal human lung fibroblast cell line 
Saponin Cmpounds [15, 81, Supporting 
Data II]  
Cytotoxicities 
Ethanol extracts induced apoptosis in human leukemic cell lines Ethanol Etracts [101] 
Anti-mutagenic Activity Exhibited an anti-mutagenic potential on MNNG mutagenicity 
using rat hepatocytes 
Ehanolic Etracts [102] 
Extracts Inhibited cytokine-stimulated, iNOS-dependent synthe-
sis of nitric oxide in murine endothelial cells, without affecting 
cell viability 
Extracts [103] Anti-inflammatory Ac-
tivities 
Reduced myeloperoxidase activity strongly in the inflamed tissue 
of the acute model 
Polar Sterols [21] 
Aqueous extracts of the leaves and roots inhibited the hemolytic 
activity of the snake and scorpion venoms 
Aqueous Extracts [24] 
Ethanol extracts of the leaves and roots enhanced RBC hemoly-
sis on red blood cells 
Ethanol Extracts [24] 
Anti-snake and Scorpion 
Venoms Effects 
Inhibited the contraction of isolated tracheal smooth musle of 
rabbits and 
Aqueous Extract [106] 
Exhibited selective antibacterial activity against Salmonella 
species and the Erwinia genus of bacteria 
Eryngial [108, 109] 
Exhibited activity against parasitic trypanosomes, nematodes, 
fungi and bacteria in humans and other mammals 
Eryngial [109] 
Exhibited antifungal activity with MIC values of 0.16-0.32 
μg/mL against several dermatophyte species 
Volatile Extracts [110] 
Showed antimycotic activity Saponin Mixture 
Extracts 
[111, 113, 114] 
Showed antimicrobial activities against 12 bacterial and yeast 
strains 
Chloroformic Fractions  
 
[112] 
Antibacterial, Antifungal, 
and Antimalarial Activi-
ties 
Showed antiplasmodial activity against Plasmodium falciparum 
with IC50 of 25 μg/mL and P. gallinaceum which infects hickens 
Extracts [109] 
Exhibited antioxidant activity in in vitro assays Rosmarinic acid analogs  
Extracts 
[13, 115-121] 
Exhibited different levels of antioxidant activity six in vitro 
assays at both flowering and non-flowering stage 
Methanol Extracts [26, 122] 
Exhibited weak radical scavenging activity, low total phenol 
content 
Extracts [112] 
Antioxidant Activities 
Inhibited iron-fructose-phosphate-induced lipid peroxidation in 
lecithin liposome and linoleic acid emulsion systems  
Ethanol Extracts [123] 
Exhibited the inhibition in the velvetleaf germination (-)-2,4,4-trimethyl-3-formyl-2,5-
cyclohexadienyl angelate 
[47] Other Activities 
Exhibited anthelmintic activity against Strongyloides stercoralis Eryngial [109] 
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and chronic assay. Myeloperoxidase activity was also 
strongly reduced in the acute, but not the chronic model. 
Although stigmasterol (88) yielded from the hexane extracts 
exerted a significant topical antiinflammatory activity, by 
itself it could not account for the overall effects observed for 
the total phytosterols [21]. Further study indicated that a po-
lar sterol should be responsible for the so-called medicinal 
property of the plant [99]. Aadditionally, a decoction from 
the leaves of E. foetidum exhibited significantly dose-
dependent anti-inflammatory activity by inhibiting the 
carrageenan-induced oedema in rat paw. However, oral 
administration was less active than topical administration. 
This decoction also potently decreased the number of 
abdominal writhings provoked by acetic acid as the pain 
stimulus [105].  
Anti- Snake and Scorpion Venoms Effects 
Traditionally, many Eryngium species were used to pre-
vent and treat snake bites and scorpion stings [10]. Modern 
pharmacologic investigations are only limited to E. creticum. 
E. creticum has been used in folk medicine in Jordan as a 
remedy for scorpion stings in the rural areas and as a hypo-
glycemic agent [17]. Aqueous extracts of both fresh and 
dried roots as well as fresh leaves of E. creticum gave 100% 
or a higher percentage inhibition of the hemolytic activity of 
the snake and scorpion venoms. However, ethanol extract of 
the leaves and roots enhanced red blood cell (RBC) hemoly-
sis rather than inhibiting venom activities on RBC [24]. 
Aqueous extract of the roots inhibited the contraction of iso-
lated tracheal smooth musle of rabbits and guinea pigs 
caused by Leiurus quinquestriatus scorpion venom, and also 
prolonged the life of guinea pigs from 20 min to 8 h when 
injected by a Jordanian L. quinquestriatus scorpion venom 
[106, 107].  
Antibacterial, Antifungal, and Antimalarial Activities 
The aerial plant parts of E. foetidum exhibited selective 
antibacterial activity against Salmonella species and the Er-
winia genus of bacteria [108, 109]. A fraction of the essential 
oil rich in eryngial is the subject of a US patent application 
for its effectiveness against parasitic trypanosomes, nema-
todes, fungi and bacteria in humans and other mammals 
[109]. The volatile extracts of E. duriaei subsp. juresianum 
Table 5. Biological Activities of Eryngium as Revealed by In Vivo Studies 
Bioactivities Animal Model Description Bioactive Agents Reference 
Mice Inhibited carrageenan-induced hind paw oedema 
and TPA-induced ear oedema tests 
Ethanol Extracts [22] 
Mice Showed antinociceptive activity in the p-
benzoquinone-induced writhing test 
Ethanol Extracts [22] 
Mice Reduced the auricular oedema in acute and chronic 
assay induced by 12-0-tetradecanoylphorbol acetate 
(TPA) 
Polar Sterols [21] 
Rats Prevented inflammatory responses to s.c. injections 
of nucleic acid Na salt or ovalbumin into the hind-
paw 
Saponin Mixtures [104] 
Rats Inhibited the carrageenan-induced oedema in paw 
given orally 
Decoctions [105] 
Anti-inflammatory Activi-
ties  
 
Rats Induced the number of abdominal writhing 
provoked by acetic acid as the pain stimulus 
Decoctions [105] 
Anti- Scorpion Venoms 
Effects 
Guinea pigs prolonged the life from 20 min to 8 hr injected by 
Jordanian Leiurus quinquestriatus scorpion venom 
Aqueous Extracts [106, 107] 
Rats Reduced blood glucose concentration given orally 
in normoglycemic and streptozotocin –induced 
models 
Decoctions [17] 
Rats Exhibited substantial acute antihyperglycemic 
activities despite lacking any favorable in vitro 
effectiveness 
Aqueous Extracts [124] 
Antihyperglycemic Effects 
Rats Showed no effected in the level of glucose of the 
normoglycemic and streptozotocin –induced dia-
betic, and normal models when given a single oral 
dose 
Extracts [109] 
Rats Exhibited anti-convulsant activity at a concentra-
tion of 110 g/250 mL induced by picrotoxin 
Extracts [109, 127] Other Activities 
Rats Enhanced the permeation of piroxicam across rat 
skin 
Essential Oil [125, 126] 
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showed antifungal activity with MIC values of 0.16-0.32 
μL/mL against several dermatophyte species (Trichophyton 
mentagrophytes, T. rubrum, Epidermophyton floccosum; T. 
verrucosum, T. mentagrophytes var interdigitale, Mi-
crosporum canis and M. gypseum) [110]. In an in vitro an-
timycotic activity screening against 8 phytopathogenic fungi, 
E. creticum showed more than 95% inhibition of spore ger-
mination in at least two fungi [111]. Two extracts from E. 
maritimum L. showed antimicrobial activities against 12 
bacterial and yeast strains. The result indicated that chloro-
formic fractions were generally more active than methanolic 
ones [112]. A saponin mixture from dried leaves of E. 
planum also showed antimycotic effect [113, 114]. 
Despite the claims of traditional antimalarial use, E. foe-
tidum showed lowly in vitro antiplasmodial activity against 
Plasmodium falciparum with IC50 of 25μg/mL. Interestingly, 
in the screening of the aqueous extract of the entire plant 
against various species of Plasmodium, activity was only 
reported against P. gallinaceum which infects chickens 
thereby suggesting another possible veterinary use [109]. 
Antioxidant Activities 
There is currently an upsurge of interest in phytochem-
cals as new sources of natural antioxidants. In several in vi-
tro antioxidant activity screening, many Eryngium species 
used as edible plants [115] and/or herbs in Thailand [116], 
Jordanian origin [117], Vietnamese [118], European [119], 
Sardinia [120], and Iran [121] have been demonstrated to 
have the antioxidant activity in tested models. 
The roots of E. alpinum were shown to have highly anti-
oxidant activity toward the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical in a TLC autographic assay. By further bio-
assay fractionation, compounds 82, 83 and 85 were found to 
respond for the activity. Related to the activity of ascorbic 
acid, the antioxidant activity of 82 was almost one-fold 
higher than 83, and similar to 84. The results are consistent 
with published reports indicating that the position and/or the 
number of glycosyl groups present in the molecule plays a 
significant part in the antioxidant activity [13].  
Methanol extracts of leaves and inflorescence of E. cau-
casicum at flowering stage, which was found recently as a 
new cultivated vegetable plant in home gardens in northern 
Iran, were investigated for their antioxidant activities em-
ploying six in vitro assay systems. Extracts exhibited differ-
ent levels of antioxidant activity in all the models studied. 
Extracts showed very good scavenging activity of H2O2 with 
IC50 of 25.5 mg/mL for leaves and 177.2 mg/mL for inflo-
rescence, respectively; IC50 for DPPH radical-scavenging 
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Table 6. Inhibitory Activity Against DNA Topoisomerases and Cytotoxicity Against Human Tumors of Some Oleanane-type 
Triterpenoids and Triterpenoid Glycosides 
Activity (IC50) (μM) Cytotoxicity (GI50) (μM) No. Name R1 R2 R3 R4 R5 R6 R7 
TOP1 TOP2 A549 PC-3 HL-60 PANC-1 MRC-5 
1 Eryngiioside J OH OH O-Ang Ac Ara COOH H (-) (-) 4.3±0.34 5.08±0.38 7.36±0.28 11.45±0.75 5.61±1.27 
2 Saniculasaponin III OH OH O-Ang Ac Xyl COOH H (-) (-) 4.73±0.21 8.51±0.71 7.11±0.55 16.02±0.61 3.54±0.34 
3 Eryngiioside L H OH O-Ang Ac Xyl COOH H (-) (-) 8.35±2.89 11.32±1.60 8.41±1.84 13.0±1.27 8.71±1.45 
4 21-angeloyloxy-3-[-
D-glucopyranosyl-
(12)]-[-D-
xylopyranosyl-(13)]--
D-
glucuronopyranosyloxy-
olean-12-ene-15, 16, 
22, 28-tetrol 
OH OH O-Ang H Ara COOH H (-) (-) 7.34±0.46 7.99±0.29 9.38±1.48 (-) 8.51±1.27 
5 Eryngioside F H OH OH Ang Xyl COOH H (-) (-) (-) (-) (-) (-) (-) 
6 Eryngioside E OH OH OH Ang Xyl COOH H (-) (-) (-) (-) (-) (-) (-) 
7 Eryngioside H OH OH H Ang Ara COOH H (-) (-) 1.0±0.15 2.12±0.11 3.65±1.00 12.71±2.19 5.61±0.71 
8 Eryngioside I OH OH H Ang Xyl  COOH H (-) (-) 1.2±0.16 2.71±0.06 2.19±0.68 7.06±0.94 4.59±0.36 
9 Eryngioside A H OH H Glc H CH2OH Glc (-) (-) (-) (-) (-) (-) (-) 
10 Eryngioside B H OH H Glc H CH2OH Gal (-) (-) (-) (-) (-) (-) (-) 
11 Eryngioside C H O H Glc H CH2OH Glc (-) (-) (-) (-) (-) (-) (-) 
Notes: DNA Topoisomerase Inhibitory Activity: For active compounds, IC50 (mean ± S.D.) refers to the concentration required to inhibit 50% of TOP1 activity. (-) indicates that the 
compound is inactive (negative at 312 M or with IC50 >250 μM). Cytotoxicity: GI50 (mean ± S.D.) refers to the concentration required to have 50% cell-growth inhibition; (-) indi-
cates that the compound is inactive at 25 μM 
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activity was 0.15 for leaves and 0.39 mg/mL for inflores-
cence; leaves extract exhibited better Fe
2+
 chelating ability 
(IC50 = 0.25 mg/mL) than that of EDTA (IC50 = 18 μg/mL) 
[26]. The research group also reported a good antioxidant 
activity of leaves of E. caucasicum at non-flowering stage 
using the same assay systems. However, these are so differ-
ent from flowering stages. The leave extracts at non-
flowering stage showed stronger NO scavenging and peroxi-
dation inhibition, and very less scavenging activity of H2O2, 
reducing powers and Fe
2+ 
chelating ability than leaves and 
inflorescence at flowering stage [122].  
Eryngium maritimum exhibited weak radical scavenging 
activity (IC50 = 0.28 mg/mL), low total phenol content (16.4 
mg/g), as well as relatively strong total antioxidant activities 
(from 32.7 to 48.6 mg/g) [112]. Ethanol extract of E. billar-
dieri significantly inhibited iron-fructose-phosphate-induced 
lipid peroxidation in lecithin liposome and linoleic acid 
emulsion systems [123]. 
Antihyperglycemic Effects 
A research indicated that an aqueous decoction from E. 
creticum caused significant reductions in blood glucose con-
centration when given orally in normoglycemic and strepto-
zocin-hyperglycemic rats [17]. The aqueous extracts of E. 
creticum exhibited substantial acute antihyperglycemic ac-
tivities in starch-treated rats, despite lacking any favorable in 
vitro effectiveness [124]. In a preliminary oral glucose-
tolerance evaluation, a single (acute) oral dose of the leaf 
extract from E. foetidum did not cause significant reduction 
in the level of glucose of the models tested [109]. 
In addition, some other bioactivity and pharmacological 
properties of Eryngium also report. (-)-2,4,4-trimethyl-3-
formyl-2,5-cyclohexadienyl angelate (46), only active com-
pound isolated from the hexane extract of seeds from E. 
paniculatum was found to inhibit germination of velvetleaf 
[47]. The essential oil of E. bungei and E. caeruleum at the 
5.0% concentration provided an almost 9.17-fold and 8.56-
fold increase in permeability coefficients of piroxicam across 
rat skin [125, 126]. Pharmacological studies of the aerial 
plant parts of E. foetidum L. included also anthelmintic ac-
tivity due to eryngial and anti-convulsant activity at a con-
centration of 110 g/250 mL induced by picrotoxin in the re-
spective models [109, 127]. Eryngium foetidum is one of 
four plants used in a Japanese patent for having developed a 
skin-whitening agent [109]. 
CONCLUSIONS 
Eryngium has been cultivated as ornamental, vegetable, 
and medicinal crops. However, phytochemistry and pharma-
cological properties of most of the 250 species remain unex-
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Fig. (1). Effects of Eryngioside H and I on the proliferation of human non-small cell lung cells (A549). 
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Fig. (2). Effects of Eryngioside H and I on the proliferation of human pancreatic cancer cells (PANC-1). 
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plored. From the 23 species, at least 127 compounds have 
been isolated and identified. These are primarily non-
essential oil compounds such as terpenoids, triterpenoid 
saponins, flavonoids, coumarins, polyacetylenes, and ster-
oids. These 23 species represent nine to 11 sections of Eryn-
gium in both Old and New Worlds. Initial data indicated that 
triterpenoid saponins, terpenoids, coumarins may be re-
stricted to certain sections. Because the chemical investiga-
tions for the most of these species except E. campestre and 
E. yuccifolium are preliminary and incomplete, chemotaxo-
monical significance of these compounds will not be re-
vealed until extensive investigations including more species.  
Eryngium extracts or isolates have shown in vitro and in 
vivo activitities such as cytotoxicity against various human 
tumor cell lines, anti-inflammatory, anti-snake and scorpion 
venoms, antibacterial, antifungal, and antimalarial, antioxi-
dant, and antihyperglycemic effects. There are no clinical 
data related to the numerous ethno medicinal uses. The mo-
lecular mechanisms of bioactivities (particularly cytotoxicity 
and anti-snake and scorpion venoms) of Eryngium isolates 
remain elusive. Also, chemical isolation and modification 
and animal tests of polyhydroxylated triterpenoid saponins 
may provide interesting lead for cancer drug development.  
ABBREVIATIONS 
A549 = Human lung adenocarcinoma epithelial cell 
line 
Ang = Angeloyl 
Ac = Acetyl 
dMA = ,-dimethylacryloyl  
DPPH = 2,2-diphenyl-1-picrylhydrazyl 
EDTA = Ethylenediaminetetraacetic acid 
HL-60 = Human promyelocytic leukemia cell line  
HCT 116 = Human colon adenocarcinoma epithelial 
cell line 
HT-29 = Human colon adenocarcinoma epithelial 
cell line 
iNOS = Inducible nitric oxide synthase 
LPS = Lipopolysaccharide 
MNNG = N-methyl-N-nitro-N-nitroso-guanidine 
MRC-5 = Human normal lung cell line  
mRNA = Messenger ribonucleic acid  
PANC-1 = Human pancreatic carcinoma, epithelial-
like cell line 
PC-3 = Human prostate adenocarcinoma epithelial 
cell line  
RBC = Red blood cell 
SAR = Structure–activity relationship  
TOP1 = DNA topoisomerase I 
TOP2 = DNA topoisomerase II 
TNF = Tumor necrosis factor  
TPA = 12-O-tetradecanoylphorbol acetate  
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